scholarly journals CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis

Hepatology ◽  
2007 ◽  
Vol 45 (2) ◽  
pp. 543-544 ◽  
Author(s):  
Hermann E. Wasmuth ◽  
Christian Trautwein
Keyword(s):  
Liver Fibrosis ◽  
Cannabinoid Receptor ◽  
Receptor Antagonism ◽  
Cb1 Cannabinoid Receptor ◽  
New Strategy

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

2006 ◽  
Vol 12 (6) ◽  
pp. 671-676 ◽  
Author(s):  
Fatima Teixeira-Clerc ◽  
Boris Julien ◽  
Pascale Grenard ◽  
Jeanne Tran Van Nhieu ◽  
Vanessa Deveaux ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Cannabinoid Receptor ◽  
Receptor Antagonism ◽  
Cb1 Cannabinoid Receptor ◽  
New Strategy

scholarly journals A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation

PLoS ONE ◽  
2012 ◽  
Vol 7 (6) ◽  
pp. e38312 ◽  
Author(s):  
Alessandro Tozzi ◽  
Antonio de Iure ◽  
Valentina Marsili ◽  
Rosaria Romano ◽  
Michela Tantucci ◽  
...  
Keyword(s):  
Adenosine Receptor ◽  
Cannabinoid Receptor ◽  
Receptor Activation ◽  
A2a Adenosine Receptor ◽  
Receptor Antagonism ◽  
Cb1 Cannabinoid Receptor ◽  
Motor Effects

Falcarinol (Panaxynol) is a CB1 cannabinoid receptor antagonist and induces pro-allergic effects in skin

Planta Medica ◽  
2009 ◽  
Vol 75 (09) ◽  
Author(s):  
J Gertsch ◽  
M Leonti ◽  
L Casu ◽  
F Cottiglia ◽  
S Raduner ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cannabinoid Receptor ◽  
Cb1 Cannabinoid Receptor
Sign in / Sign up

Export Citation Format

Share Document